Interferon-γ mediated up-regulation of caspase-8 sensitises medulloblastoma cells to radio- and chemotherapy

[1]  G. Booz,et al.  Jak inhibition, but not Stat1 knockdown, blocks the synergistic effect of IFN-gamma on Fas-induced apoptosis of A549 human non-small cell lung cancer cells. , 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[2]  T. Yeatman,et al.  Tumor response to neoadjuvant chemoradiation therapy for rectal adenocarcinoma is mediated by p53-dependent and caspase 8-dependent apoptotic pathways. , 2005, Clinical colorectal cancer.

[3]  B. Sveinbjørnsson,et al.  Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL. , 2004, International journal of oncology.

[4]  Y. Ravindranath,et al.  Interferon‐γ sensitizes osteosarcoma cells to fas‐induced apoptosis by up‐regulating fas receptors and caspase‐8 , 2004, Pediatric blood & cancer.

[5]  K. McCarthy,et al.  Interferon- (cid:1) Induced Medulloblastoma in the Developing Cerebellum , 2022 .

[6]  T. Shalaby,et al.  Telomere maintenance in childhood primitive neuroectodermal brain tumors. , 2004, Neuro-oncology.

[7]  J. Houghton,et al.  Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  L. Rorke,et al.  Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  Eun-young Ahn,et al.  IFN‐γupregulates apoptosis‐related molecules and enhances Fas‐mediated apoptosis in human cholangiocarcinoma , 2002, International journal of cancer.

[10]  S. Fulda,et al.  IFNγ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway , 2002, Oncogene.

[11]  Lloyd J. Old,et al.  The roles of IFNγ in protection against tumor development and cancer immunoediting , 2002 .

[12]  P. Krammer,et al.  Tumor Immunology , 2018, Medical Immunology.

[13]  D. Sredni-Kenigsbuch.  TH1/TH2 CYTOKINES IN THE CENTRAL NERVOUS SYSTEM , 2002, The International journal of neuroscience.

[14]  B. Decallonne,et al.  An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. , 2001, Methods.

[15]  B. Smedsrød,et al.  Interferon-gamma modulates TRAIL-mediated apoptosis in human colon carcinoma cells. , 2001, Anticancer research.

[16]  L. Rorke,et al.  Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas. , 2001, European journal of cancer.

[17]  Chilakamarti V. Ramana,et al.  Biologic consequences of Stat1-independent IFN signaling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Richard M. Ransohoff,et al.  Stat1-independent regulation of gene expression in response to IFN-γ , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. López-Rivas,et al.  Interferon-γ Sensitizes Human Myeloid Leukemia Cells to Death Receptor-mediated Apoptosis by a Pleiotropic Mechanism* , 2001, The Journal of Biological Chemistry.

[20]  C. Niemeyer,et al.  Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis , 2001, Cell Death and Differentiation.

[21]  A. Allione,et al.  Regulation of interferon-gamma receptor (INF-gammaR) chains: a peculiar way to rule the life and death of human lymphocytes. , 2001, European cytokine network.

[22]  R. Ho,et al.  Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. , 2001, Cancer research.

[23]  A. López-Rivas,et al.  Interferon-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program. , 2000, Cancer research.

[24]  A. Eggert,et al.  Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression , 2000, Oncogene.

[25]  F. LaFerla,et al.  Regional hypomyelination and dysplasia in transgenic mice with astrocyte-directed expression of interferon-γ , 2000, Journal of Molecular Neuroscience.

[26]  F. Behm,et al.  Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN , 2000, Nature Medicine.

[27]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[28]  C. Belka,et al.  The tyrosine kinase Lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation , 1999, Oncogene.

[29]  I. H. Engels,et al.  Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. , 1999, Blood.

[30]  E. Solary,et al.  STAT-1-independent upregulation of FADD and procaspase-3 and -8 in cancer cells treated with cytotoxic drugs. , 1999, Biochemical and biophysical research communications.

[31]  L. Rorke,et al.  Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  B. Popko,et al.  Oligodendroglial Response to the Immune Cytokine Interferon Gamma , 1999, Neurochemical Research.

[33]  J. Blenis,et al.  Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade , 1998, Current Biology.

[34]  R. Schreiber,et al.  Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice , 1998 .

[35]  I. Herr,et al.  The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. , 1997, Cancer research.

[36]  J. Kurtzberg,et al.  High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  B. Popko,et al.  The effects of interferon-γ on the central nervous system , 1997, Molecular Neurobiology.

[38]  H. Mohri,et al.  Interferon-γ InducesIceGene Expression and Enhances Cellular Susceptibility to Apoptosis in the U937 Leukemia Cell Line ☆ , 1996 .

[39]  D. Goeddel,et al.  A death-domain-containing receptor that mediates apoptosis , 1996, Nature.

[40]  J. Darnell,et al.  Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Widschwendter,et al.  Increased radiosensitivity by a combination of 9-cis-retinoic acid and interferon-y in breast cancer cells. , 1996, Gynecologic oncology.

[42]  I. Herr,et al.  Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells , 1996, Nature Medicine.

[43]  B. Popko,et al.  Targeted CNS Expression of Interferon-γ in Transgenic Mice Leads to Hypomyelination, Reactive Gliosis, and Abnormal Cerebellar Development , 1996, Molecular and Cellular Neuroscience.

[44]  A. Eggert,et al.  Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma. , 2002, European journal of cancer.

[45]  Y. Hamada,et al.  Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma , 2000, Cancer Chemotherapy and Pharmacology.

[46]  L. Ries,et al.  Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. , 1999 .

[47]  M. Rosenblum,et al.  High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  U. Boehm,et al.  Cellular responses to interferon-gamma. , 1997, Annual review of immunology.

[49]  M Aguet,et al.  The IFN gamma receptor: a paradigm for cytokine receptor signaling. , 1997, Annual review of immunology.